Patients with intestinal polyps
Conditions
Interventions
Experimental group:remimazolam tosylate
Control group:propofol
Sponsors
The First Affiliated Hospital of Shantou University Medical College
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Receive elective intestinal polypectomy; 2. The medical history, signs, auxiliary examination and other information are complete; 3. Age 18-80 years old, gender is not limited; 4. BMI 18-28 kg/m2; 5. Understand and voluntarily participate in the research, and sign the informed consent; 6. The ASA classification is I-II level.
Exclusion criteria
Exclusion criteria: 1. History of allergy to benzodiazepines, butorphanol tartrate, propofol; 2. Infection at the injection site; 3. Suffering from uncontrolled hypertension, diabetes, heart failure and other chronic diseases; 4. Hypovolemia, shock or coma; 5. Suffering from serious system diseases such as heart, lung, blood, liver and kidney; 6. Mental or nervous system problems, communication barriers and unable to cooperate; 7. History of drug abuse and alcoholism; 8. Women who are pregnant or breastfeeding; 9. It is difficult to maintain normal vital signs during the operation, or serious complications occur and need to be transferred to the ICU; 10. Participated in a drug clinical trial as a subject within the past 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hypotension; | — |
Secondary
| Measure | Time frame |
|---|---|
| propofol consumption; | — |
Countries
China
Contacts
Public ContactWei Sun
The First Affiliated Hospital of Shantou University Medical College
Outcome results
None listed